This precision treatment for malignant tumors successfully delivers the drug to the tumor site through the endothelial barrier under external guidance, while also promoting drug entry into the tumor tissue through P-selectin-dependent endocytosis, thereby inhibiting tumor progression. Here, SELP is linked to neoplasm.